79351011 - KALVISTA

Information

• Trademark
• 79351011

• Source

• Serial Number

  79351011

• Registration Number

  7147580

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  July 20, 2022
  2 years ago

• Registration Date

  August 29, 2023
  a year ago

• Transaction Date

  October 23, 2023
  a year ago

• Status Date

  August 29, 2023
  a year ago

• Published for Opposition Date

  June 13, 2023
  a year ago

• Location Date

  August 29, 2023
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  JOINER, KATINA JACKSON

• Law Office Assigned Location Code

  L40

• Owners

  • KalVista Pharmaceuticals Limited

Case File Statements

• GS0051: Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular edema; pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders
• GS0441: Medical and healthcare services relating to ophthalmic diseases and disorders; medical and health care services relating to diabetic macular edema; medical and healthcare services relating to angioedema; medical and healthcare services relating to hereditary angioedema; medical and healthcare services relating to diseases and disorders mediated by the contact activation system; medical and healthcare services relating to plasma kallikrein or factor XIIa mediated diseases or disorders
• GS0101: Medical and surgical instruments and apparatus for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders; drug delivery devices for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders
• GS0421: Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or factor XIIa mediated diseases or disorders

Case File Event Statements

• 10/23/2023 - a year ago

  12 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 9/29/2023 - a year ago

  11 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 9/29/2023 - a year ago

  10 - FINAL DISPOSITION PROCESSED Type: FIMP

• 9/28/2023 - a year ago

  9 - GRANT OF PROTECTION CREATED, TO BE SENT TO IB Type: GPAR

• 8/29/2023 - a year ago

  8 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/13/2023 - a year ago

  7 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/24/2023 - a year ago

  6 - NOTICE OF PUBLICATION Type: NPUB

• 5/6/2023 - a year ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/5/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 10/4/2022 - 2 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 9/30/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/29/2022 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR